EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...
Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's ...
Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...
The IDMC identified no significant safety issues and recommended moving forward with enrolling the second dose cohort, expected to begin in Q1 2025. AMT-162 utilizes a novel approach designed to ...
HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This ...
My assignment that morning was to document Trump’s return to the White House, four years after voters had sent him into exile – and just two months after they’d decided he deserved a second ...
Plus: Mac Miller's Balloonerism debuts in the top five. By Keith Caulfield Bad Bunny’s Debí Tirar Más Fotos captures a second week at No. 1 on the Billboard 200 albums chart (dated Feb. 1 ...
No. 4 Alabama men's basketball outlasted LSU 80-73 on Saturday. The Crimson Tide put together a strong second half to pull away with the victory, but Alabama All-American point guard Mark Sears ...
Moderna's stock roared higher on the back of news about potential AI mRNA vaccines. The company also secured a supply contract in Europe. Shares of Moderna are down 90%, and the company has a huge ...